Peer Review History

Original SubmissionAugust 20, 2024
Decision Letter - Bedilu Linger Endalifer, Editor

PONE-D-24-35370Univariate Screening and Multivariate Analysis of Factors Influencing Dignity Impairment in Elderly Patients with Incontinence-Associated Dermatitis: A Lasso and Logistic Regression ApproachPLOS ONE

Dear Dr. nie,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

  • Address the following comments

This are my comments to the authors

General comments

  • It needs grammar edition (capitalization,…)

  1. Title should be modified as - Factors Influencing Dignity Impairment in Elderly Patients with Incontinence-Associated Dermatitis: A Lasso and Logistic Regression Approach
  2. Limited keywords- add more  words

Introduction

  1. In line 35 a statement: This condition can affect skin areas beyond the perineum. Have no reference
  2. Statement in line 45-47 - Current research both domestically and internationally mainly focuses on the 46 prevention and treatment of IAD symptoms, with limited studies addressing 47 psychological aspects, especially in the domain of dignity. Cite reference

General: the introduction part should be clearly stated and written with sufficient information

  • Problem statement of Dignity Impairment
  • Potential significance of your study
  • Use appropriate reference

Materials and Method

In line 85: Exclusion criteria: you stated that history of depression within the past three months; diagnosis 86 of psychiatric disorders; presence of other severe, incurable chronic diseases; 87 participation in concurrent psychological intervention studies. Why 3 months? Do you mean that psychiatric disease onset within three months does not affect the results?

Line 88: This study has been 88 approved by the hospital’s ethics committee: remove from this part

Discussion

Avoid subtitle in the discussion part

The discussion part is lacking, it needs more scientific justification

==============================

Please submit your revised manuscript by Feb 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Bedilu Linger Endalifer

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

3. Please amend your authorship list in your manuscript file to include author jinlei du, xiaoling wu, ling lei, hongxiang Zhao, qiyu zhang, yuanxia wang, yao chen, jiquan zhang, chencong nie.

4. Please include a separate caption for each figure in your manuscript.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

Reviewer #3: Yes

Reviewer #4: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Here are my comments on the key aspects.

Technical soundness and data support:

The manuscript is partly technically sound, with data that partly supports the conclusions. The study addresses an important topic with an adequate sample size and appropriate statistical methods. However, there are some limitations.

-The cross-sectional design limits causal inferences about risk factors.

-There's limited information on the validity of the dignity assessment scale used.

-Some potential confounding factors (e.g. IAD severity, comorbidities) appear not to have been controlled for.

-Addressing these issues would strengthen the conclusions.

Statistical analysis:

The statistical analysis appears appropriate and rigorous. It is appropriate to use Lasso regression followed by logistic regression to identify risk factors. The sample size calculation and reporting of odds ratios with confidence intervals are appropriate. However, more details on the specific statistical procedures would be beneficial.

Manuscript presentation:

The manuscript is clearly written in standard English, with a logical structure that effectively communicates the study's objectives, methods, results, and conclusions.

Additional comments:

-Provide more details on how IAD was diagnosed and graded.

-Clarify the validity and reliability of the dignity assessment scale used.

-Discuss potential confounding factors not accounted for in the analysis.

Overall, this study provides valuable initial data on an important topic, but addressing the noted limitations would significantly strengthen the manuscript.

Reviewer #2: There is no data on the functional status of the subjects .How many had poor functional status ? Dignity is proportional to independent status .Also gender of care giver ,whether care giver was a hired care giver ,spouse or daughter or son or daughter in law or a qualified nurse is important to know .Such a high prevalence of dermatitis has been reported .Were subjects using incontinence solutions such as diapers or leak proof pants ?

How was the cognitive status of elders who answered the dignity questionnaire ?were they literate or illiterate

Very often dermatitis is due to candidal intertrigo which is curable with antifungal agents .Was there pain which impaired quality of life

comparison of dignity questinnaire of incontinent people with dignity of a patient suffering from cancer is not appropriate

Reviewer #3: The research article exhibits several methodological and presentation-related errors that warrant attention. Firstly, the use of convenience sampling introduces selection bias, potentially limiting the generalizability of the findings. While the LASSO regression approach is appropriate, details on hyperparameter tuning and comprehensive multicollinearity diagnostics (e.g., variance inflation factor values) are missing, reducing the study's reproducibility. The sample size slightly exceeds the calculated requirement without a clear explanation, and potential confounders, such as education level and urban/rural residence, are not fully addressed. Furthermore, the discussion lacks depth in contextualizing findings, particularly in offering actionable interventions for identified protective and risk factors. Ethical considerations, while mentioned, do not detail measures taken to mitigate psychological distress during data collection. Additionally, vague statements about data availability ("on reasonable request") hinder transparency, and referenced figures and tables are absent in the manuscript, impacting the clarity of the presented results. Minor grammatical inconsistencies and overly complex sentences further detract from the article's readability and coherence.

Reviewer #4: It is not prudent to specify a statistical test in the title, even if it may be informative.

In the introduction, the importance of the study is not adequately specified. It is important to expand the topic and references based on points such as the management of dermatological diseases in older adults, the quality of life in people with urinary incontinence.

The study design is not defined.

It is understood that if the study is analytical according to the title, a sample size for only one population should not be used.

In the exclusion criteria, it is not specified what types of incurable or severe diseases, the presence or absence of disability or functional impairment, and whether they had any other type of dermatological condition.

It is not specified when talking about the dignity test the cutoff point for evaluating its deterioration.

In the statistical section, they detail the type of analysis and the procedure for a multivariate analysis. It is also important to detail the assumptions for conducting this analysis and whether all of them were met.

Urinary incontinence is not evaluated as a confounding variable because it can itself alter the patient's dignity, as the test assesses dignity in a global manner and not defined by diseases.

In the discussion: the comparison should ideally be with chronic and/or dermatological pathologies in this population.

Explain how they addressed the limitations and strengths of the study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  RICHARD AMOAKO

Reviewer #2: No

Reviewer #3: Yes:  Salman Ashfaq Ahmad

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Dear Editor,Thank you for the valuable guidance and revision suggestions provided by you and the reviewers. We have uploaded all our responses in the attached file, named "Response to Editor and Reviewers."

Attachments
Attachment
Submitted filename: Response to Editor and reviewers.docx
Decision Letter - Bedilu Linger Endalifer, Editor

Factors Influencing Dignity Impairment in Elderly Patients with Incontinence-Associated Dermatitis: A Lasso and Logistic Regression Approach

PONE-D-24-35370R1

Dear Dr. du,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Bedilu Linger Endalifer

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Bedilu Linger Endalifer, Editor

PONE-D-24-35370R1

PLOS ONE

Dear Dr. du,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Bedilu Linger Endalifer

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .